The Patent Finder
PB

Prince Biotech, LLC

First filing 2004
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Five patents currently held, every record listed here

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Oct 2032. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Oct 2032
Next term end
3
Patent families

When these terms end

Each bar runs from grant to computed term end. 2017 to 2036.
US 9,737,585 Compositions and Methods for Treatment of Intracellular Damage and Bacterial Infection Oct 23, 2032
US 10,953,071 Compositions and Methods for Treatment of Intracellular Damage and Bacterial Infection Jul 14, 2033
US 11,096,987 Mutant Peptides And Methods Of Treating Subjects Using The Same Sep 16, 2035
US 12,458,681 Compositions and Method for Treating Acute Radiation Syndrome Sep 16, 2035
US 11,090,355 Compositions And Methods For The Treatment Of Neurodamage Aug 25, 2036
20212025202920332036
10 pending applications: term is not computable until grant.Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Patents held now

Soonest term end first.

Showing 1 to 5 of 5

PatentTitleStatusExpiresConfidence
US 9,737,585Compositions and Methods for Treatment of Intracellular Damage and Bacterial Infection
In force
 · High confidence
In forceHigh confidence
US 10,953,071Compositions and Methods for Treatment of Intracellular Damage and Bacterial Infection
In force
 · High confidence
In forceHigh confidence
US 11,096,987Mutant Peptides And Methods Of Treating Subjects Using The Same
In force
 · Medium confidence
In forceMedium confidence
US 12,458,681Compositions and Method for Treating Acute Radiation Syndrome
In force
 · Medium confidence
In forceMedium confidence
US 11,090,355Compositions And Methods For The Treatment Of Neurodamage
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 5: 8 patents ended · 10 applications pending · 5 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
2 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited